Sophia Genetics SA (SOPH) Stock Analysis

Sophia Genetics SA (SOPH) is a publicly traded company in the HEALTHCARE sector. It trades at $4.94, carries a market capitalization of $362.54M. This page summarizes the public market data, fundamentals, and frequently asked questions for SOPH, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $4.94
• Market Cap: $362.54M
• EPS: $-1.18
• 52-Week High: $5.70
• 52-Week Low: $2.59

Market Sentiment

Sophia Genetics SA currently has a Bearish sentiment score of -0.25.

About Sophia Genetics SA

None

GNG Research Analysis

GNG Research scores Sophia Genetics SA (SOPH) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SOPH.

Frequently Asked Questions

Does SOPH pay dividends?

Sophia Genetics SA (SOPH) does not currently pay a regular dividend.

What is SOPH's market cap?

Sophia Genetics SA (SOPH) has a market capitalization of $362.54M with a current stock price of $4.94.